Today news
The same in other media
Stimulant, Non-Stimulant, or Both? Combination Therapy for ADHD
Reading now: 908
A study by Tim Wilens, M.D., and colleagues followed children and teens who were treated for ADHD with the non-stimulant medication atomoxetine, a selective norepinephrine reuptake inhibitor (SNRI).
The children’s symptoms significantly improved; their ADHD rating scale scores dropped from a 34 to a 21. However, 21 is still quite a high level of symptoms.
I want all symptoms on the ADHD rating scale to be mild or minimal, on average, which means achieving a score under 18.So, the researchers added OROS methylphenidate to the atomoxetine, and the subjects’ ADHD symptoms dropped almost by half to 12.
At this point, there was very little functional impairment from the ADHD symptoms: all 18 symptoms were either mild or undetectable.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|